How a SheBoss CEO is Changing MedTech Titelbild

How a SheBoss CEO is Changing MedTech

How a SheBoss CEO is Changing MedTech

Jetzt kostenlos hören, ohne Abo

Details anzeigen

Nur 0,99 € pro Monat für die ersten 3 Monate

Danach 9.95 € pro Monat. Bedingungen gelten.

Über diesen Titel

 When a close family friend told her to reconsider premed and “go do something else that changes the world,” Manisha found her calling at the intersection of technology, engineering, and healthcare. Activ Surgical’s CEO Manisha Shah-Bugaj shares how she navigated her career development in healthcare, ultimately becoming the face of one of the most successful Boston-based surgical device companies. She opens up about her journey through college, how she rose the ranks in medtech, and some of her current favorite books! Read more about our speaker: Manisha Shah-Bugaj has a long-standing track record as a successful global medtech executive, key influencer and transformational leader, both globally and domestically, with a core strength in developing and protecting team culture founded in transparency, recognition, and acknowledgment of areas of improvement, with identified countermeasures. She joined Activ Surgical in January 2022 as Chief Operating Officer, responsible for overseeing all business operations for the company, including oversight of the commercialization of its ActivSight™ enhanced visualization imaging module and the implementation of its surgical visualization technology at established pilot hospital sites in 2022. Prior to Activ Surgical, Shah-Bugaj architected the gynecology unit at Olympus from the ground up in the U.S., ultimately serving as General Manager and Global Vice President for the company and played an integral role in expanding the gynecology business internationally. She has more than two decades of experience, including building and implementing corporate business plans, directing regional and global businesses aligned to financial and operational targets, hiring and establishing new teams, and managing product portfolios.
Noch keine Rezensionen vorhanden